Clinical impact of ≥50% reduction of low density lipoprotein cholesterol following lipid lowering therapy on cardiovascular outcomes in patients with acute coronary syndrome
Open Access
- 13 November 2024
- journal article
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 19 (2) , 247-255
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- National trends and disparities in statin use for ischemic heart disease from 2006 to 2018: Insights from National Ambulatory Medical Care SurveyAmerican Heart Journal, 2022
- 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood CholesterolJACC, 2019
- Interindividual Variation in Low-Density Lipoprotein Cholesterol Level Reduction With EvolocumabJAMA Cardiology, 2019
- 2013 Cholesterol Guidelines Revisited: Percent LDL Cholesterol Reduction or Attained LDL Cholesterol Level or Both for Prognosis?The American Journal of Medicine, 2016
- Very Low Levels of Atherogenic Lipoproteins and the Risk for Cardiovascular EventsJACC, 2014
- 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in AdultsJACC, 2014
- Physicians’ perception, knowledge and awareness of cardiovascular risk factors and adherence to prevention guidelines: The PERCRO-DOC surveyAtherosclerosis, 2010
- Repeated Serum Lipid Measurements During the Peri-Hospitalization PeriodThe American Journal of Cardiology, 2006
- Phenotypic Predictors of Response to Simvastatin Therapy Among African-Americans and Caucasians: The Cholesterol and Pharmacogenetics (CAP) StudyThe American Journal of Cardiology, 2006
- Myocardial injury: The acute phase response and lipoprotein metabolismJACC, 1993